iTeh StandardsiTeh Standards
EURUSD
Your shopping cart is empty.
CEN

EN ISO 13004:2023

(Main)

Sterilization of health care products - Radiation - Substantiation of selected sterilization dose: Method VDmaxSD (ISO 13004:2022)

Sterilization of health care products - Radiation - Substantiation of selected sterilization dose: Method VDmaxSD (ISO 13004:2022)

Adoption of ISO 13004:2022 – This is currently in FDIS and will be publishing in October 2022.
This document describes a method for substantiating a selected sterilization dose of 17,5,
20, 22,5, 27,5, 30, 32,5 or 35 kGy that achieves a sterility assurance level (SAL) of 10−6 or less for radiation
sterilization of health care products. This Technical Specification also specifies a method of sterilization
dose audit used to demonstrate the continued effectiveness of the substantiated sterilization dose.
NOTE Selection and substantiation of the sterilization dose is used to meet the requirements for establishing
the sterilization dose within process definition in ISO 11137-1.

Sterilisation von Produkten für die Gesundheitsfürsorge - Strahlen - Bestätigung der gewählten Sterilisationsdosis: Methode VDmaxSD (ISO 13004:2022)

Dieses Dokument beschreibt ein Verfahren zur Bestätigung einer ausgewählten Sterilisationsdosis von 17,5 kGy, 20 kGy, 22,5 kGy, 27,5 kGy, 30 kGy, 32,5 kGy oder 35 kGy, mit der ein Sterilitätssicherheitsniveau (SAL) von 10−6 oder weniger für die Strahlensterilisation von Produkten für die Gesundheitsvorsorge erreicht wird. Dieses Dokument legt darüber hinaus ein Verfahren zur Sterilisationsdosisüberprüfung fest, die zum Nachweis der beständigen Wirksamkeit der bestätigten Sterilisationsdosis verwendet wird.
ANMERKUNG 1   Auswahl und Bestätigung der Sterilisationsdosis werden angewendet, um die Anforderungen an die Ermittlung der Sterilisationsdosis im Rahmen der Verfahrensdefinition nach ISO 11137 1 zu erfüllen.
Dieses Dokument ist nicht anwendbar für andere Sterilisationsdosen, sondern ausschließlich für die Bestätigung ausgewählter Sterilisationsdosen von 17,5 kGy, 20 kGy, 22,5 kGy, 27,5 kGy, 30 kGy, 32,5 kGy und 35 kGy. Das Verfahren wird nicht zur Bestätigung einer ausgewählten Sterilisationsdosis verwendet, wenn die durchschnittliche mikrobiologische Belastung der gesamten Produkteinheit den für die ausgewählte Sterilisationsdosis festgelegten Grenzwert überschreitet (siehe Tabelle 3).
ANMERKUNG 2   Die Verfahren für die Bestätigung ausgewählter Sterilisationsdosen von 25 kGy und 15 kGy sind in diesem Dokument nicht berücksichtigt. Diese werden in ISO 11137 2 beschrieben.
Wenn die Entscheidung getroffen wird, dieses Verfahren zur Ermittlung der Sterilisationsdosis anzuwenden, ist das Verfahren zur Anwendung in Übereinstimmung mit den hier festgelegten Anforderungen (muss) und Handlungsempfehlungen (sollte) vorgesehen.

Stérilisation des produits de santé - Irradiation - Justification de la dose stérilisante choisie: Méthode DVmaxDS (ISO 13004:2022)

Sterilizacija izdelkov za zdravstveno nego - Sevanje - Utemeljitev izbrane doze sterilizacije: metoda VDmaxSD (ISO 13004:2022)

Ta dokument opisuje metodo za utemeljitev izbrane doze sterilizacije 17,5 kGy, 20 kGy, 22,5 kGy, 27,5 kGy, 30 kGy, 32,5 kGy ali 35 kGy za doseganje ravni zagotavljanja sterilnosti (SAL) 10–6 ali manj za sterilizacijo zdravstvenih pripomočkov s sevanjem. Ta dokument določa tudi metodo za presojo odmerka sterilizacije, ki se uporablja za dokaz stalne učinkovitosti utemeljenega odmerka sterilizacije.
OPOMBA 1: Izbira in utemeljitev odmerka sterilizacije se uporabljata za izpolnitev zahtev za določanje odmerka sterilizacije v sklopu definicije postopka iz standarda ISO 11137-1.
Ta dokument se ne uporablja za druge odmerke sterilizacije, razen za utemeljitev izbranega odmerka sterilizacije 17,5 kGy, 20 kGy, 22,5 kGy, 27,5 kGy, 30 kGy, 32,5 kGy ali 35 kGy. Metoda se ne uporablja za utemeljitev izbranega odmerka sterilizacije, če povprečna biološka obremenitev celotnega izdelka presega mejo, določeno za izbrani odmerek sterilizacije (glej preglednico 3).
OPOMBA 2: Metode za utemeljitev izbranih odmerkov sterilizacije 25 kGy in 15 kGy niso vključene v ta dokument. Opisane so v standardu ISO 11137-2.
Če se sprejme odločitev, da se uporabi ta metoda za določanje sterilizacije odmerka, je predvideno, da se sledi metodi skladno z zahtevami (je treba) in navodili (naj), določenimi v tem dokumentu.

General Information

Status
Published
Publication Date
27-Jun-2023
ICS
11.080.01 - Sterilization and disinfection in general
Technical Committee
CEN/TC 204 - Sterilization of medical devices
Drafting Committee
CEN/TC 204 - Sterilization of medical devices
Current Stage
6060 - Definitive text made available (DAV) - Publishing
Start Date
28-Jun-2023
Due Date
28-Mar-2025
Completion Date
28-Jun-2023
Ref Project
SIST EN ISO 13004:2023 - Sterilization of health care products - Radiation - Substantiation of selected sterilization dose: Method VDmaxSD (ISO 13004:2022)

Relations

Replaces
CEN ISO/TS 13004:2014 - Sterilization of health care products - Radiation - Substantiation of selected sterilization dose: Method VDmaxSD (ISO/TS 13004:2013)
Effective Date
19-Jan-2023

Buy Standard

EN ISO 13004:2023EN ISO 13004:2023
PreviousNext
Standard
EN ISO 13004:2023
English language
63 pages
sale 10% off
Preview
sale 10% off
Preview
e-Library read for
1 day

Standards Content (Sample)

SLOVENSKI STANDARD
SIST EN ISO 13004:2023
01-september-2023
Nadomešča:
SIST-TS CEN ISO/TS 13004:2014
Sterilizacija izdelkov za zdravstveno nego - Sevanje - Utemeljitev izbrane doze
sterilizacije: metoda VDmaxSD (ISO 13004:2022)
Sterilization of health care products - Radiation - Substantiation of selected sterilization
dose: Method VDmaxSD (ISO 13004:2022)
Sterilisation von Produkten für die Gesundheitsfürsorge - Strahlen - Bestätigung der
gewählten Sterilisationsdosis: Methode VDmaxSD (ISO 13004:2022)
Stérilisation des produits de santé - Irradiation - Justification de la dose stérilisante
choisie: Méthode DVmaxDS (ISO 13004:2022)
Ta slovenski standard je istoveten z: EN ISO 13004:2023
ICS:
11.080.01 Sterilizacija in dezinfekcija na Sterilization and disinfection
splošno in general
SIST EN ISO 13004:2023 en,fr,de
2003-01.Slovenski inštitut za standardizacijo. Razmnoževanje celote ali delov tega standarda ni dovoljeno.

---------------------- Page: 1 ----------------------
SIST EN ISO 13004:2023

---------------------- Page: 2 ----------------------
SIST EN ISO 13004:2023


EN ISO 13004
EUROPEAN STANDARD

NORME EUROPÉENNE

June 2023
EUROPÄISCHE NORM
ICS 11.080.01 Supersedes CEN ISO/TS 13004:2014
English Version

Sterilization of health care products - Radiation -
Substantiation of selected sterilization dose: Method
SD
VD (ISO 13004:2022)
max
Stérilisation des produits de santé - Irradiation - Sterilisation von Produkten für die
Justification de la dose stérilisante choisie: Méthode Gesundheitsfürsorge - Strahlen - Bestätigung der
DS SD
DV (ISO 13004:2022) gewählten Sterilisationsdosis: Methode VD (ISO
max max
13004:2022)
This European Standard was approved by CEN on 26 June 2023.

CEN members are bound to comply with the CEN/CENELEC Internal Regulations which stipulate the conditions for giving this
European Standard the status of a national standard without any alteration. Up-to-date lists and bibliographical references
concerning such national standards may be obtained on application to the CEN-CENELEC Management Centre or to any CEN
member.

This European Standard exists in three official versions (English, French, German). A version in any other language made by
translation under the responsibility of a CEN member into its own language and notified to the CEN-CENELEC Management
Centre has the same status as the official versions.

CEN members are the national standards bodies of Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia,
Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway,
Poland, Portugal, Republic of North Macedonia, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Türkiye and
United Kingdom.





EUROPEAN COMMITTEE FOR STANDARDIZATION
COMITÉ EUROPÉEN DE NORMALISATIO N

EUROPÄISCHES KOMITEE FÜR NORMUN G

CEN-CENELEC Management Centre: Rue de la Science 23, B-1040 Brussels
© 2023 CEN All rights of exploitation in any form and by any means reserved Ref. No. EN ISO 13004:2023 E
worldwide for CEN national Members.

---------------------- Page: 3 ----------------------
SIST EN ISO 13004:2023
EN ISO 13004:2023 (E)
Contents Page
European foreword . 3

2

---------------------- Page: 4 ----------------------
SIST EN ISO 13004:2023
EN ISO 13004:2023 (E)
European foreword
The text of ISO 13004:2022 has been prepared by Technical Committee ISO/TC 198 "Sterilization of
health care products” of the International Organization for Standardization (ISO) and has been taken
over as EN ISO 13004:2023 by Technical Committee CEN/TC 204 “Sterilization of medical devices” the
secretariat of which is held by BSI.
This European Standard shall be given the status of a national standard, either by publication of an
identical text or by endorsement, at the latest by December 2023, and conflicting national standards
shall be withdrawn at the latest by December 2023.
Attention is drawn to the possibility that some of the elements of this document may be the subject of
patent rights. CEN shall not be held responsible for identifying any or all such patent rights.
This document supersedes CEN ISO/TS 13004:2014.
Any feedback and questions on this document should be directed to the users’ national standards body.
A complete listing of these bodies can be found on the CEN website.
According to the CEN-CENELEC Internal Regulations, the national standards organizations of the
following countries are bound to implement this European Standard: Austria, Belgium, Bulgaria,
Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland,
Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal,
...

Questions, Comments and Discussion

Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.

This May Also Interest You

CEN
EN ISO 17664-2:2023(Main)
Processing of health care products - Information to be provided by the medical device manufacturer for the processing of medical devices - Part 2: Non-critical medical devices (ISO 17664-2:2021)
SIST EN ISO 17664-2:2024

This document specifies requirements for the information to be provided by the medical device manufacturer for the processing of non-critical medical devices not intended to be sterilized (i.e. a medical device that is intended to come into contact with intact skin only or a medical device not intended for direct patient contact).
This includes information for processing prior to use or reuse of the medical device.
Processing instructions are not defined in this document. Rather, this document specifies requirements to assist manufacturers of medical devices in providing detailed processing instructions that consist of the following activities, where applicable:
a)   preparation before processing;
b)   cleaning;
c)   disinfection;
d)   drying;
e)   inspection and maintenance;
f)    packaging;
g)   storage;
h)   transportation.
This document excludes processing of:
1)   critical and semi-critical medical devices;
2)   medical devices intended to be sterilized;
3)   textile medical devices used in patient draping systems or surgical clothing;
4)   medical devices specified by the manufacturer for single use only and supplied ready for use.
NOTE     See Annex E for further guidance on the application of the ISO 17664 series to a medical device.

  • Standard
    34 pages
    English language
    sale 10% off
    e-Library read for
    1 day
CEN
CEN ISO/TS 11137-4:2023(Main)
Sterilization of health care products - Radiation - Part 4: Guidance on process control (ISO/TS 11137-4:2020)
SIST-TS CEN ISO/TS 11137-4:2023

This document provides additional guidance to that given in ISO 11137-3 on meeting the requirements specified in ISO 11137-1, ISO 11137-2 and ISO/TS 13004 for the establishment and control of a radiation sterilization process using gamma, electron beam, and X-irradiation.

  • Technical specification
    64 pages
    English language
    sale 10% off
    e-Library read for
    1 day
CEN
EN ISO 11137-2:2015/A1:2023(Amendment)
Sterilization of health care products - Radiation - Part 2: Establishing the sterilization dose - Amendment 1 (ISO 11137-2:2013/Amd 1:2022)
SIST EN ISO 11137-2:2015/A1:2023

2022-06-21 - lack of compliance - publication on hold

  • Amendment
    13 pages
    English language
    sale 10% off
    e-Library read for
    1 day
CEN
EN ISO 25424:2019/A1:2022(Amendment)
Sterilization of health care products - Low temperature steam and formaldehyde - Requirements for development, validation and routine control of a sterilization process for medical devices - Amendment 1 (ISO 25424:2018/Amd 1:2022)
SIST EN ISO 25424:2020/A1:2022

2022-01-13 - TC decision is missing to skip FV - publication on hold.

  • Amendment
    15 pages
    English language
    sale 10% off
    e-Library read for
    1 day
CEN
EN ISO 17664-1:2021(Main)
Processing of health care products - Information to be provided by the medical device manufacturer for the processing of medical devices - Part 1: Critical and semi-critical medical devices (ISO 17664-1:2021)
SIST EN ISO 17664-1:2021

This document specifies requirements for the information to be provided by the medical device manufacturer for the processing of critical or semi-critical medical devices (i.e. a medical device that enters normally sterile parts of the human body or a medical device that comes into contact with mucous membranes or non-intact skin) or medical devices that are intended to be sterilized.
This includes information for processing prior to use or reuse of the medical device.
Processing instructions are not defined in this document. Rather, this document specifies requirements to assist manufacturers of medical devices in providing detailed processing instructions that consist of the following activities, where applicable:
a) initial treatment at the point of use;
b) preparation before cleaning;
c) cleaning;
d) disinfection;
e) drying;
f) inspection and maintenance;
g) packaging;
h) sterilization;
i) storage;
j) transportation.
This document excludes processing of the following:
—    non-critical medical devices unless they are intended to be sterilized;
—    textile devices used in patient draping systems or surgical clothing;
—    medical devices specified by the manufacturer for single use only and supplied ready for use.
NOTE       See ISO 17664-2:2021, Annex E, for further guidance on the application of the ISO 17664 series to a medical device.

  • Standard
    34 pages
    English language
    sale 10% off
    e-Library read for
    1 day
CEN
EN ISO 14160:2021(Main)
Sterilization of health care products - Liquid chemical sterilizing agents for single-use medical devices utilizing animal tissues and their derivatives - Requirements for characterization, development, validation and routine control of a sterilization process for medical devices (ISO 14160:2020)
SIST EN ISO 14160:2021

This document specifies requirements for the characterization of a liquid chemical sterilizing agent and for the development, validation, process control and monitoring of sterilization by liquid chemical sterilizing agents of single-use medical devices comprising, in whole or in part, materials of animal origin.
This document covers the control of risks arising from contamination with bacteria and fungi by application of a liquid chemical sterilization process. Risks associated with other microorganisms can be assessed using other methods (see NOTE 1).
This document is not applicable to material of human origin.
This document does not describe methods for the validation of the inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents (see NOTE 2 and NOTE 3).
This document does not describe methods for validation of the inactivation or elimination of protozoa and parasites.
The requirements for validation and routine control described in this document are only applicable to the defined sterilization process of a medical device, which is performed after the manufacturing process, and do not take account of the lethal effects of other bioburden reduction steps (see NOTE 4).
This document does not specify tests to establish the effects of any chosen sterilization process upon the fitness for use of the medical device (see NOTE 5).
This document does not cover the level of residual sterilizing agent within medical devices (see NOTE 6).
Guidance for the characterization of a liquid chemical sterilizing agent and for the development, validation, process control and monitoring of sterilization by liquid chemical sterilizing agents of single-use medical devices comprising, in whole or in part, materials of animal origin is provided in informative Annex A.
NOTE 1  The prior application of risk management principles to medical devices utilizing animal tissues, as described in ISO 22442-1 is important. ISO 18362 provides information on control of microbial risks during processing of cell-based health-care products.
NOTE 2  Liquid chemical sterilizing agents traditionally employed to sterilize animal tissues in medical devices might not be effective in inactivating the causative agents of TSE such as bovine spongiform encephalopathy (BSE), or scrapie. Satisfactory validation in accordance with this document does not necessarily demonstrate inactivation of infective agents of this type. Risk controls related to sourcing, collection and handling of animal materials are described in ISO 22442-2.
NOTE 3  The validation of the inactivation, elimination, or elimination and inactivation of viruses and TSE agents is described in ISO 22442-3.
NOTE 4  Manufacturing processes for medical devices containing animal tissues frequently include exposure to chemical agents which can significantly reduce the bioburden on the medical device. Following the manufacturing process, a medical device is exposed to a specified sterilization process.
NOTE 5  Such testing is a crucial part of the design and development of a medical device.
NOTE 6  ISO 10993-17 specifies a method to establish allowable limits for residues of sterilizing agents.
NOTE 7  Standards for quality management systems (see ISO 13485) can be used in the control of all stages of manufacture including the sterilization process.

  • Standard
    50 pages
    English language
    sale 10% off
    e-Library read for
    1 day
CEN
EN ISO 11737-1:2018/A1:2021(Amendment)
Sterilization of health care products - Microbiological methods - Part 1: Determination of a population of microorganisms on products - Amendment 1 (ISO 11737-1:2018/Amd 1:2021)
SIST EN ISO 11737-1:2018/A1:2021
  • Amendment
    13 pages
    English language
    sale 10% off
    e-Library read for
    1 day
CEN
EN ISO 13408-6:2021(Main)
Aseptic processing of health care products - Part 6: Isolator systems (ISO 13408-6:2021)
SIST EN ISO 13408-6:2021

This document specifies the requirements for and provides guidance on the specification, selection, qualification, bio-decontamination, validation, operation and control of isolator systems related to aseptic processing of health care products and processing of cell-based health care products.
This document does not specify requirements for restricted access barrier systems (RABS).
This document does not supersede or replace national regulatory requirements such as Good Manufacturing Practices (GMPs) and/or compendia requirements that pertain in particular to national or regional jurisdictions.
This document does not specify requirements for isolators used for sterility testing; however, some of the principles and information in this document could be applicable to this application.
This document does not define biosafety containment requirements.

  • Standard
    39 pages
    English language
    sale 10% off
    e-Library read for
    1 day
CEN
EN ISO 11737-2:2020(Main)
Sterilization of health care products - Microbiological methods - Part 2: Tests of sterility performed in the definition, validation and maintenance of a sterilization process (ISO 11737-2:2019)
SIST EN ISO 11737-2:2020

1.1    This document specifies the general criteria for tests of sterility on medical devices that have been exposed to a treatment with the sterilizing agent which has been reduced relative to that anticipated to be used in routine sterilization processing. These tests are intended to be performed when defining, validating or maintaining a sterilization process.
1.2    This document is not applicable to:
a)    sterility testing for routine release of product that has been subjected to a sterilization process,
b)    performing a test for sterility (see 3.12),
NOTE 1    The performance of a) or b) is not a requirement of ISO 11135, ISO 11137-1, ISO 11137-2, ISO 14160, ISO 14937, ISO 17665-1 or ISO 20857.
c)    test of sterility or test for sterility for demonstration of product shelf life, stability and/or package integrity, and
d)    culturing of biological indicators or inoculated products.
NOTE 2    Guidance on culturing biological indicators is included in ISO 11138-7.

  • Standard
    35 pages
    English language
    sale 10% off
    e-Library read for
    1 day
CEN
EN ISO 25424:2019(Main)
Sterilization of health care products - Low temperature steam and formaldehyde - Requirements for development, validation and routine control of a sterilization process for medical devices (ISO 25424:2018)
SIST EN ISO 25424:2020

1.1    Inclusions
1.1.1    This document specifies requirements for the development, validation and routine control of a low temperature steam and formaldehyde (LTSF) sterilization process for medical devices using a mixture of low temperature steam and formaldehyde as sterilizing agent and which operates below ambient pressure.
NOTE       Although the scope of this document is limited to medical devices, it specifies requirements and provides guidance that can be applicable to other products and equipment.
1.1.2    This document is intended to be applied by process developers, manufacturers of sterilization equipment, manufacturers of medical devices to be sterilized and the organizations with responsibility for sterilizing medical devices (see ISO 14937:2009, Table E.1).
1.2    Exclusions
1.2.1    This document does not specify requirements for the development, validation and routine control of a process for inactivating the causative agents of spongiform encephalopathies such as scrapie, bovine spongiform encephalopathy and Creutzfeldt-Jakob disease. Specific recommendations have been produced in particular countries for the processing of materials potentially contaminated with these agents.
NOTE       See ISO 22442‑1, ISO 22442‑2 and ISO 22442‑3.
1.2.2    This document does not specify requirements for designating a medical device as "STERILE". Such requirements are given in EN 556‑1.
1.2.3    This document does not specify a quality management system for the control of all stages of production of medical devices.
NOTE       It is not a requirement of this document to have a complete quality management system during manufacture or reprocessing, but those elements of such a system that are required are normatively referenced at appropriate places in the text. Attention is drawn to the standards for quality management systems (see ISO 13485) that control all stages of production or reprocessing of medical devices including the sterilization process. Further guidance is given in E.4 of ISO 14937:2009.
1.2.4    This document does not specify requirements for occupational safety associated with the design and operation of LTSF sterilization facilities.
NOTE 1    Safety requirements for sterilizers are specified in IEC 61010‑2‑040.
NOTE 2    Attention is also drawn to the existence in some countries of regulations stipulating safety requirements.
1.2.5    This document does not cover analytical methods for determining levels or residues of formaldehyde and/or its reaction products.
NOTE 1    Attention is drawn to EN 14180.
NOTE 2    Attention is drawn to the possible existence in some countries of statutory regulations specifying limits for the level of formaldehyde residues on medical devices and products.
1.2.6    This document does not cover preparatory measures that might be necessary before sterilization such as cleaning, disinfection and packing.
NOTE       For reprocessable medical devices, the manufacturer(s) of these devices can supply information on the preparatory measures (see ISO 17664).

  • Standard
    63 pages
    English language
    sale 10% off
    e-Library read for
    1 day